Cargando…
Using the WHO Essential Medicines List to Assess the Appropriateness of Insurance Coverage Decisions: A Case Study of the Croatian National Medicine Reimbursement List
PURPOSE: To investigate the use of the WHO EML as a tool with which to evaluate the evidence base for the medicines on the national insurance coverage list of the Croatian Institute of Health Insurance (CIHI). METHODS: Medicines from 9 ATC categories with highest expenditures from 2012 CIHI Basic Li...
Autores principales: | Jeličić Kadić, Antonia, Žanić, Maja, Škaričić, Nataša, Marušić, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206465/ https://www.ncbi.nlm.nih.gov/pubmed/25337860 http://dx.doi.org/10.1371/journal.pone.0111474 |
Ejemplares similares
-
Impact of delisting OTC medicines from reimbursement list
por: Chytilová, Petra, et al.
Publicado: (2015) -
A comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicines
por: Mustafa, Asma Abubakr, et al.
Publicado: (2010) -
Monographs for medicines on WHO’s Model List of Essential Medicines
por: Roth, Lukas, et al.
Publicado: (2018) -
Availability of Authorizations from EMA and FDA for Age-Appropriate Medicines Contained in the WHO Essential Medicines List for Children 2019
por: delMoral-Sanchez, Jose-Manuel, et al.
Publicado: (2020) -
Revising the WHO Essential Medicines List for paediatric rheumatology
por: Scott, Christiaan, et al.
Publicado: (2021)